Screener
Humana HUM Cash, Cash Equivalents, and Marketable Securities
Cash, Cash Equivalents, and Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by Humana in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.
The source filing: Humana’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 2:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000049071-26-000050
| Commercial | 301 | (3) | 685 | (45) | 986 | (48) | ||||||
| Asset-backed securities | 578 | (4) | 191 | (13) | 769 | (17) | ||||||
| Corporate debt securities | 3,522 | (55) | 3,371 | (369) | 6,893 | (424) | ||||||
| Total debt securities | $ | $7,994 | $ | $(126) | $ | $7,370 | $ | $(863) | $ | $15,364 | $ | $(989) |
| December 31, 2025 | ||||||||||||
| U.S. Treasury and other U.S. government corporations and agencies: | ||||||||||||
| U.S. Treasury and agency obligations | $ | $643 | $ | $(7) | $ | $857 | $ | $(32) | $ | $1,500 | $ | $(39) |
| Mortgage-backed securities | 593 | (3) | 2,373 | (333) | 2,966 | (336) |
Item 6. Exhibits [53](#ia86f76420e744c99a4e0b1c9d7af6cd5_127)
FAQ
- What is Humana's cash, cash equivalents, and marketable securities?
- Humana (HUM) reported cash, cash equivalents, and marketable securities of $15.36B in Q2 2026.
- How has Humana's cash, cash equivalents, and marketable securities changed year-over-year?
- Humana's cash, cash equivalents, and marketable securities increased by 18.3% year-over-year, from $12.98B to $15.36B.
- What is the long-term trend for Humana's cash, cash equivalents, and marketable securities?
- Over 5 years (2020 to 2025), Humana's cash, cash equivalents, and marketable securities has grown at a 46.6% compound annual growth rate (CAGR), from $1.63B to $11.07B.
- What does cash, cash equivalents, and marketable securities mean?
- This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.
Ask your AI about Humana's cash, cash equivalents, and marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude